Reuters logo
BRIEF-AGTC appoints Matthew Feinsod, M.D. as interim chief medical officer
September 5, 2017 / 10:12 PM / in a month

BRIEF-AGTC appoints Matthew Feinsod, M.D. as interim chief medical officer

Sept 6 (Reuters) - Applied Genetic Technologies Corp

* AGTC appoints Matthew Feinsod, M.D. as interim chief medical officer

* Applied Genetic Technologies Corp - ‍Feinsod will replace Michael Goldstein, who is leaving to pursue other career opportunities​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below